Quantitative in-depth analysis of the dynamic secretome of activated Jurkat T-cells

Journal of Proteomics

Volumn 75, Issue 2, 2011, Pages 561-571

  Bonzon Kulichenko, Elena ^a   Martínez Martínez, Sara ^b   Trevisan Herraz, Marco ^a   Navarro, Pedro ^c   Redondo, Juan Miguel ^b   Vázquez, Jesús ^a,b  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c ETH ZURICH   (Switzerland)

Author keywords

18O labeling; Jurkat T cells; Mass spectrometry; Quantitative proteomics; Secretion; Secretome

Indexed keywords

CELL PROTEIN; OXYGEN 18; PROTEOME; SECRETOME; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LIQUID CHROMATOGRAPHY; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TANDEM MASS SPECTROMETRY; UPREGULATION;

CELL PROLIFERATION; CHROMATOGRAPHY, LIQUID; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; NEOPLASM PROTEINS; PROTEOME; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TANDEM MASS SPECTROMETRY; UP-REGULATION;

EID: 82355161388     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.08.022     Document Type: Article

References (53)

1. Schenk S., Schoenhals G.J., de Souza G., Mann M. A high confidence, manually validated human blood plasma protein reference set. BMC Med Genomics 2008, 1:41.
2. Cochran D.A., Evans C.A., Blinco D., Burthem J., Stevenson F.K., Gaskell S.J., et al. Proteomic analysis of chronic lymphocytic leukemia subtypes with mutated or unmutated Ig V(H) genes. Mol Cell Proteomics 2003, 2:1331-1341.
3. Cui J.W., Wang J., He K., Jin B.F., Wang H.X., Li W., et al. Proteomic analysis of human acute leukemia cells: insight into their classification. Clin Cancer Res 2004, 10:6887-6896.
4. Cui J.W., Wang J., He K., Jin B.F., Wang H.X., Li W., et al. Two-dimensional electrophoresis protein profiling as an analytical tool for human acute leukemia classification. Electrophoresis 2005, 26:268-279.
5. Sundrud M.S., Torres V.J., Unutmaz D., Cover T.L. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci USA 2004, 101:7727-7732.
6. Grolleau A., Bowman J., Pradet-Balade B., Puravs E., Hanash S., Garcia-Sanz J.A., et al. Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J Biol Chem 2002, 277:22175-22184.
7. Tu X., Huang A., Bae D., Slaughter N., Whitelegge J., Crother T., et al. Proteome analysis of lipid rafts in Jurkat cells characterizes a raft subset that is involved in NF-kappaB activation. J Proteome Res 2004, 3:445-454.
8. Woo A.J., Dods J.S., Susanto E., Ulgiati D., Abraham L.J. A proteomics approach for the identification of DNA binding activities observed in the electrophoretic mobility shift assay. Mol Cell Proteomics 2002, 1:472-478.
9. Wu L., Hwang S.I., Rezaul K., Lu L.J., Mayya V., Gerstein M., et al. Global survey of human T leukemic cells by integrating proteomics and transcriptomics profiling. Mol Cell Proteomics 2007, 6:1343-1353.
10. Wu C.C., Hsu C.W., Chen C.D., Yu C.J., Chang K.P., Tai D.I., et al. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol Cell Proteomics 2010, 9:1100-1117.
11. Nair R., Rost B. Mimicking cellular sorting improves prediction of subcellular localization. J Mol Biol 2005, 348:85-100.
12. Nickel W. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 2003, 270:2109-2119.
13. Rubartelli A., Cozzolino F., Talio M., Sitia R. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J 1990, 9:1503-1510.
14. Jackson A., Friedman S., Zhan X., Engleka K.A., Forough R., Maciag T. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc Natl Acad Sci USA 1992, 89:10691-10695.
15. Mignatti P., Morimoto T., Rifkin D.B. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 1992, 151:81-93.
16. Hughes R.C. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1999, 1473:172-185.
17. Joliot A., Maizel A., Rosenberg D., Trembleau A., Dupas S., Volovitch M., et al. Identification of a signal sequence necessary for the unconventional secretion of Engrailed homeoprotein. Curr Biol 1998, 8:856-863.
18. Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002, 3:995-1001.
19. Denny P.W., Gokool S., Russell D.G., Field M.C., Smith D.F. Acylation-dependent protein export in Leishmania. J Biol Chem 2000, 275:11017-11025.
20. Emanuelsson O., Brunak S., von Heijne G., Nielsen H. Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc 2007, 2:953-971.
21. 18O labeling. Mol Cell Proteomics 2011, 10. M110 003335.
22. 16O labeling and linear ion trap mass spectrometry: application to the study of vascular endothelial growth factor-induced angiogenesis in endothelial cells. Mol Cell Proteomics 2009, 8:1130-1149.
23. Shevchenko A., Tomas H., Havlis J., Olsen J.V., Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006, 1:2856-2860.
24. Katayama H., Tabata T., Ishihama Y., Sato T., Oda Y., Nagasu T. Efficient in-gel digestion procedure using 5-cyclohexyl-1-pentyl-beta-d-maltoside as an additive for gel-based membrane proteomics. Rapid Commun Mass Spectrom 2004, 18:2388-2394.
25. Lopez-Ferrer D., Martinez-Bartolome S., Villar M., Campillos M., Martin-Maroto F., Vazquez J. Statistical model for large-scale peptide identification in databases from tandem mass spectra using SEQUEST. Anal Chem 2004, 76:6853-6860.
26. Ortega-Perez I., Cano E., Were F., Villar M., Vazquez J., Redondo J.M. c-Jun N-terminal kinase (JNK) positively regulates NFATc2 transactivation through phosphorylation within the N-terminal regulatory domain. J Biol Chem 2005, 280:20867-20878.
27. Jorge I., Casas E.M., Villar M., Ortega-Perez I., Lopez-Ferrer D., Martinez-Ruiz A., et al. High-sensitivity analysis of specific peptides in complex samples by selected MS/MS ion monitoring and linear ion trap mass spectrometry: application to biological studies. J Mass Spectrom 2007, 42:1391-1403.
28. Martinez-Bartolome S., Navarro P., Martin-Maroto F., Lopez-Ferrer D., Ramos-Fernandez A., Villar M., et al. Properties of average score distributions of SEQUEST: the probability ratio method. Mol Cell Proteomics 2008, 7:1135-1145.
29. Navarro P., JS V.Z. A refined method to calculate False Discovery Rates for peptide identification using decoy databases. J Proteome Res 2009.
30. Bendtsen J.D., Jensen L.J., Blom N., Von Heijne G., Brunak S. Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel 2004, 17:349-356.
31. Krogh A., Larsson B., von Heijne G., Sonnhammer E.L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 2001, 305:567-580.
32. 18O labeling and linear ion trap mass spectrometry. Proteomics 2006, 6(Suppl 1):S4-S11.
33. 18O labeling with a correction for labeling efficiency. Mol Cell Proteomics 2007, 6:1274-1286.
34. Northrop J.P., Ho S.N., Chen L., Thomas D.J., Timmerman L.A., Nolan G.P., et al. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 1994, 369:497-502.
35. Martinez-Martinez S., Gomez del Arco P., Armesilla A.L., Aramburu J., Luo C., Rao A., et al. Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells. Mol Cell Biol 1997, 17:6437-6447.
36. Fan H., Derynck R. Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J 1999, 18:6962-6972.
37. Martinez-Lacaci I., Johnson G.R., Salomon D.S., Dickson R.B. Characterization of a novel amphiregulin-related molecule in 12-O-tetradecanoylphorbol-13-acetate-treated breast cancer cells. J Cell Physiol 1996, 169:497-508.
38. Salo T., Turpeenniemi-Hujanen T., Tryggvason K. Tumor-promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (type IV) collagen-degrading metalloproteinase by human fibroblasts. J Biol Chem 1985, 260:8526-8531.
39. Rossner S., Mendla K., Schliebs R., Bigl V. Protein kinase Calpha and beta1 isoforms are regulators of alpha-secretory proteolytic processing of amyloid precursor protein in vivo. Eur J Neurosci 2001, 13:1644-1648.
40. Zheng Y., Saftig P., Hartmann D., Blobel C. Evaluation of the contribution of different ADAMs to tumor necrosis factor alpha (TNFalpha) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNFalpha convertase (TACE/ADAM17). J Biol Chem 2004, 279:42898-42906.
41. Rodriguez-Tarduchy G., Sahuquillo A.G., Alarcon B., Bragado R. Apoptosis but not other activation events is inhibited by a mutation in the transmembrane domain of T cell receptor beta that impairs CD3zeta association. J Biol Chem 1996, 271:30417-30425.
42. Wu C.C., Chen H.C., Chen S.J., Liu H.P., Hsieh Y.Y., Yu C.J., et al. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 2008, 8:316-332.
43. Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003, 3:791-800.
44. Bernhagen J., Calandra T., Mitchell R.A., Martin S.B., Tracey K.J., Voelter W., et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993, 365:756-759.
45. Bacher M., Metz C.N., Calandra T., Mayer K., Chesney J., Lohoff M., et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996, 93:7849-7854.
46. Nishihira J., Koyama Y., Mizue Y. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 1998, 10:199-205.
47. Lue H., Kleemann R., Calandra T., Roger T., Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 2002, 4:449-460.
48. Rammes A., Roth J., Goebeler M., Klempt M., Hartmann M., Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997, 272:9496-9502.
49. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001, 19:242-247.
50. Cornish C.J., Devery J.M., Poronnik P., Lackmann M., Cook D.I., Geczy C.L. S100 protein CP-10 stimulates myeloid cell chemotaxis without activation. J Cell Physiol 1996, 166:427-437.
51. Eue I., Pietz B., Storck J., Klempt M., Sorg C. Transendothelial migration of 27E10+ human monocytes. Int Immunol 2000, 12:1593-1604.
52. Dunlap S.M., Celestino J., Wang H., Jiang R., Holland E.C., Fuller G.N., et al. Insulin-like growth factor binding protein 2 promotes glioma development and progression. Proc Natl Acad Sci USA 2007, 104:11736-11741.
53. Wang G.K., Hu L., Fuller G.N., Zhang W. An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility. J Biol Chem 2006, 281:14085-14091.